ArticleFrontiers in endocrinology2026
Association between
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This multicenter retrospective cohort study investigates the association between in vitro fertilization (IVF) and gestational diabetes mellitus (GDM) risk across demographic subgroups. Methods: Using clinical data from 61,329 pregnant women (3,902 IVF-conceived; 57,427 naturally conceived) across three tertiary hospitals in China, we compared GDM incidence diagnosed through standardized oral glucose tolerance tests (24-28 gestational weeks). Results: The IVF group exhibited significantly higher GDM incidence (17.32% vs. 12.91%, p<0.001). The analysis adjusted for age, parity, pre-pregnancy body mass index (BMI), family history of DM, alanine aminotransferase (ALT), and creatinine revealed IVF-conceived pregnancies had 15% elevated GDM risk. Subgroup analyses demonstrated heightened IVF-associated GDM risk in women aged <35 years, those with pre-pregnancy BMI <24 kg/m Discussion: These findings identify IVF as an independent GDM risk factor, particularly in younger, leaner, and first-time mothers. The results underscore the importance of stratified prenatal monitoring and mechanistic investigations into fertility treatments' metabolic impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.